ArticleInternational immunopharmacology2022

Evaluation of the efficacy of four anti-SARS-CoV-2 antibodies after vaccination using kits from two manufacturers: A prospective, longitudinal, cohort study at 11 serial time points within 160 days.

Lin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.